ClinicalTrials.gg
TerminatedNCT05589519PEEKPilotSBUpdated Aug 26, 2025

Partial Implant-supported Rehabilitation Using PEEK

An interventional study of Partial rehabilitation using PEEK in Prosthesis Survival, sponsored by Malo Clinic. Terminated at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-26.

Sponsored by Malo Clinic · Not applicable, Interventional, and Treatment

Why this study was terminated
Invibio Ltd decided to leave the market and stop PEEK production
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to evaluate the outcome of a Poly-ether-ether-ketone - used in partial implant-supported rehabilitations after one year of follow-up. The main question it aims to answer is:

- What is the survival outcome of partial implant-supported prosthesis using Poly-ether-ether-ketone? The participants already rehabilitated with dental implants will receive a definitive 3 unit prosthesis incorporating Poly-ether-ehter-ketone.

Read the detailed description

Following the previous study on the full-arch rehabilitation of edentulous jaws using hybrid prostheses with polyetheretherketone (PEEK) infrastructure and acrylic resin teeth supported by implants in immediate function inserted through the All-on-4 concept it is necessary to further extend the evaluation to the partial rehabilitation using 3 Unit fixed prostheses supported by dental implants. To test this, the study design to be used will be a single-centre, prospective, observational cohort study to evaluate the short term outcome of fixed prosthetic implant-supported rehabilitations. The sample of this study consists in 10 patients consecutively treated. The cohort will be evaluated at 4 to 8 weeks, 6 months and 12 months after dental loading and annually thereafter as long as the patient is willing, regarding: prosthetic survival including repair and relining, implant survival, marginal bone resorption, incidence of mechanical complications [loosening or fracture of prosthetic components), biological complications (peri-implant infection, suppuration, abscess, fistulae), patient tissue reaction, aesthetic examination including denture staining, colour stability and anatomic form; patients' in-mouth comfort and quality of life using the Oral Health Impact Profile OHIP-14 questionnaire; and assessment of prosthetic preparation (technician satisfaction), laboratory preparation time, clinical operative time and costs.

02

Conditions studied

  • Prosthesis Survival

Browse trials for

Keywords

  • prosthesis
  • dental implants
  • PEEK
03

In context

Prosthesis Failure

119 studies on the registry are indexed under Prosthesis Failure; 35 are open to participants now.

This study's enrollment of 5 is below the median of 36 across 69 interventional studies indexed under Prosthesis Failure.

Browse Prosthesis Failure studies →

Lead sponsor

Malo Clinic is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients rehabilitated with dental implants and a 3 unit Bridge where the molars are missing in one jaw, with at least both canines present;
  • Subjects who, in the opinion of the Investigator, are able to understand this clinical study, co-operate with the procedures and are willing to return to the clinic for all the required post-operative follow-ups;
  • Subjects who are able to give voluntary, written to participate in this clinical study and from whom consent has been obtained.

Exclusion criteria

Exclusion Criteria:

  • Female Subjects who are pregnant;
  • Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-ups or treatment outcomes;
  • Subjects who are currently enrolled in a clinical study;
  • Subjects requiring or currently having ongoing orthodontic treatment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Partial rehabilitation using PEEK

    A 3-unit implant-supported fixed prosthesis using PEEK polymer in its composition for the rehabilitation of the partial edentulous.

    Device: Partial rehabilitation using PEEK

Interventions

  • DevicePartial rehabilitation using PEEK

    A 3-unit implant-supported fixed prosthesis using PEEK polymer in its composition delivered as definitive prosthesis for partial rehabilitation of edentulous jaws.

    Also known as: PEEK prosthesis

06

What researchers measure

Primary outcomes

  1. Survival of the prosthesis

    Evaluation of the survival for the implant-supported prosthesis; nominal (survival,failure)

    Time frame: one year

Secondary outcomes

  1. Survival of the implants

    Evaluation of the survival for implants supporting the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)

    Time frame: one year

  2. Incidence of biological complications

    Peri-implant infection, abscess, fistulae, suppuration, sinus infection, gingival dehiscence; Nominal (no incidence, incidence)

    Time frame: one year

  3. Incidence of mechanical complications

    Loosening or fracture of prosthetic components; Nominal (no incidence, incidence)

    Time frame: one year

  4. Marginal bone resorption

    Measured through periapical radiographs, in mm between the implant shoulder and the most apical portion of implant-bone contact; Scale

    Time frame: one year

  5. Denture staining

    Veneer staining; 0:heavily stained; 10: no stains

    Time frame: one year

  6. Denture colour stability

    Veneer colour stability. Visual analoge scale (0-10 cm); 0: heavily destabilized colour; 10: complete colour stability

    Time frame: one year

  7. Denture anatomic form

    Anatomic form stability. Visual analogue scale (0-10 cm); 0: heavy loss of anatomical shape; 10: complete anatomic stability.

    Time frame: one year

  8. Patient tissue reaction

    Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    Time frame: one year

  9. ln mouth comfort

    Patient in mouth comfort. Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    Time frame: one year

  10. Oral Health Impact Profile OHIP-14

    Oral Health Impact Profile OHIP-14 questionnaire

    Time frame: one year

  11. Laboratory preparation time

    Average laboratory time to produce the finished prosthesis, the active technician time spent in Computer assisted design, Computer assisted manufacture, mill and veneering.

    Time frame: one year

  12. Clinical operative time

    Average operative time to load the final prosthesis

    Time frame: one year

07

Study locations

1 site
  • Malo Clinic
    Lisbon, Lisbon District 1600-042, Portugal
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized database containing the study variables

Supporting information: Statistical analysis plan

Time frame: Upon study completion and for 8 years.

Access criteria: Upon solicitation to the Investigators

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2022 to primary completion in Mar 2025, 29 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2022
First posted
Oct 21, 2022
StartActual
Oct 3, 2022
Primary completionActual
Mar 31, 2025
CompletionActual
Mar 31, 2025
Last update
Aug 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05589519
Lead sponsor
Malo Clinic
Collaborators
Invibio Ltd
Responsible party
Sponsor
First posted
Oct 21, 2022
Start date
Oct 3, 2022
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025
Last update
Aug 26, 2025

Study contacts

Miguel A de Araújo Nobre, PhD
principal investigator · Director of Research, Development and Education

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion